Navigation Links
OncoGenex Pharmaceuticals to Webcast Financial Results for Fourth Quarter and Fiscal Year 2008 and Provide Outlook for 2009
Date:3/4/2009

BOTHELL, WA and VANCOUVER, March 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and fiscal year 2008 financial results will be released on Wednesday, March 11, 2009, and that the Company will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. Management will discuss the company's financial results and provide a 2009 corporate outlook.

A live webcast and slide presentation will be available through the Events and Presentations Web page found in the Investors Relations section of the OncoGenex Web site at http://ir.oncogenex.com. Alternatively, you may access the live conference call by dialing 877-874-1569 (U.S. & Canada) or 719-325-4767 (International). A webcast replay will be available approximately two hours after the call and will be archived at the same Web location for 90 days.

About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase 1 clinical development; SN2310 has completed the Phase 1 clinical trial; and CSP-9222 and OGX-225 are currently in pre-clinical development. More information about OncoGenex is available at www.oncogenex.com.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Revolutionary Science, the ... colony counter, announced today that they have expanded their ... , the IncuCount, IntelliCount, InCount and ImpressCount. These ... are especially useful in food microbiology and pharmaceutical manufacturing. ... updated look. A bright white enclosure with jet ...
(Date:5/21/2013)... 2013 SoundConnect is pleased to announce ... for customers in Canada. Lync is the next ... allow businesses and organizations to collaborate and communicate much ... Lync in the United States. With the progressive rollout ... release in Canada, SoundConnect now offers a complete Microsoft ...
(Date:5/20/2013)... Al Khaimah, UAE (PRWEB) May 21, 2013 ... private equity consultancy specializing in “game-changing” life science and ... of Ms. Dalia Dergham to its International Project Team. ... to bring even greater multi-cultural depth to Grace Century ... projects around the globe. , Ms. Dergham holds both ...
(Date:5/20/2013)...  Dr. Gerald Zon , noted ... launched a new blog in conjunction with TriLink BioTechnologies. ... focuses on what,s trending in the field of nucleic ... discussions of research presented at conferences and meetings, reviews ... Zon (PhD Princeton University 1971) developed automated synthesis of ...
Breaking Biology Technology:Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2
... SG Biofuels , a bioenergy crop company using breeding ... formally launched business operations in Brazil and introduced Brazilian ... advisor for the market. Reinach will provide ... SG Biofuels Brasil, LTD, a subsidiary of SG Biofuels ...
... - Researchers are developing a new class of ... optical technologies, including ultrapowerful microscopes and computers, improved ... The new materials could make possible "nanophotonic" devices ... professor of electrical and computer engineering at Purdue ...
... forces between atoms and surfaces with unprecedented precision, University ... our understanding of the structure of atoms and improve ... Physical Review Letters . Van der Waals ... they are among the weakest known chemical interactions, so ...
Cached Biology Technology:SG Biofuels Launches Operations in Brazil; Appoints Fernando Reinach as Senior Advisor 2New materials may bring advanced optical technologies, cloaking 2Physicists take new look at the atom 2Physicists take new look at the atom 3Physicists take new look at the atom 4
(Date:5/19/2013)... women of European descent inherit common foot disorders, such ... hammer or claw toe. Findings from the Framingham Foot ... in humansappear in Arthritis Care & Research , ... American College of Rheumatology (ACR). , Previous studies ... have foot disorders which may limit mobility and reduce ...
(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) explores ... the impact of coffee on autoimmune disease and palliative ... recently has been associated with reduced risk of fibrosis, ... cups of java each month also correlate with lower ... the Mayo Clinic, Rochester, MN, linked coffee consumption with ...
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... A two-year energy audit of Hamilton schools ... their energy costs by almost $2.4 million annually. ... students at McMaster University The measures, presented ... Board and the Hamilton-Wentworth Catholic District School Board, ...
... CLEVELAND NeoProteomics Inc., a biomarker development ... agreement with Case Western Reserve University. The deal ... of cancer, diabetes, and inflammatory diseases. Proteomics ... of protein structures of biological systems. NeoProteomics, founded ...
... been shown to help reduce the formation of amyloid ... in the development of Alzheimer,s disease, according to researchers ... published their findings, "Pharmacologic Blockade of 5-Lipoxygenase,Improves the Amyloidotic ... American Journal of Pathology . In previous ...
Cached Biology News:School energy audits find millions in potential energy savings 2School energy audits find millions in potential energy savings 3Case Western Reserve and NeoProteomics announce exclusive option 2Asthma drug could help control or treat Alzheimer's disease 2
...
Synaptic Vesicle I Sampler Kit 10g each...
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Ubiquitin Related I Sampler Kit 10 mu g each...
Biology Products: